1

From: Jeffrey Siskind <jeffsiskind@msn.com>

Sent: Tuesday, August 2, 2016 4:47 PM

To: fwise@swirnowcapital.com

Subject: CannaMED

Attachments: 3Gen Subscription.docx

Frank ‐ please review the attached short form subscription agreement.  

Case 19-01298-MAM Doc 473-22 Filed 10/22/20 Page 1 of 3
SISKIND LEGAL GROUP

525 South Flagler Drive, Ste. 500 West Palm Beach, FL 33401

TEL (561) 832-7720 FAX (561) 832-7668 jefffsiskind@msn.com

August 2, 2016

3Gen VC, LLC

c/o Jerald C. Cantor

4000 Hollywood Boulevard, Ste. 500-N

Hollywood, FL 33401

RE: CannaMED Pharmaceuticals, LLC

Sale of 2% Non-Dilutable Unit Subscription and Additional 2% Option

Dear Mr. Cantor:

This shall confirm the sale by Chance & Anthem, LLC (“C&A”) to 3Gen VC, LLC 

(“Investor”) of two (2) non-dilutable units of CANNAMED PHARMACEUTICALS, LLC 

(“CannaMED”), which units comprise two percent (2%) of the total outstanding units of 

CannaMED.

By accepting receipt of this unit subscription, Investor represents that it has undertaken 

sufficient due diligence to determine that CannaMED suffices as a prudent investment, including 

review of the application materials which were submitted by CannaMED to the Natalie LaPrade 

Medical Cannabis Commission, State of Maryland, and that Investor is deemed a “sophisticated 

investor” as defined by rules promulgated by the United States Securities and Exchange 

Commission.

By accepting this subscription, you further agree that in the event that CannaMED does 

not receive necessary licensing which will enable it to conduct its business, your receipt of the 

sum of $100,000 shall suffice to conclude this agreement, and that upon said refund CannaMED, 

Chance & Anthem, LLC and the undersigned shall be released from any and all liability which 

might otherwise arise hereunder.

As additional consideration for Investor’s purchase of units as herein set forth, Investor 

shall have the right to purchase an additional 2% at the same price as paid herein, provided that 

said additional purchase be accomplished within sixty (60) days of Investor being notified that 

CannaMED has been awarded all licenses necessary to conduct its business.

In addition to the foregoing, Investor has also received a mortgage lien on a parcel of real

property located at 3445 Santa Barbara Drive, Wellington, Florida 33414 (the “Project”) owned 

by and being developed by C&A. In the event that CannaMED does not receive a grower’s 

license, Investor shall remain secured to said real property until Investor is repaid its investment 

in full. If CannaMED is successful in receiving a grower’s license, said mortgage lien shall be 

released by Investor.

Case 19-01298-MAM Doc 473-22 Filed 10/22/20 Page 2 of 3
Pg. 2 of 2

August 2, 2016

CannaMED Pharmaceuticals, LLC

Finally, you agree that the terms of this agreement and information contained in any of 

the materials which were provided to you shall be kept strictly confidential absent written 

authorization, except as necessary to enforce your rights.

Time is of the essence in concluding this transaction, which C&A may cancel in the event 

that a unit is conveyed to a third party by means of an arms-length sale upon a price and/or terms 

more favorable to C&A prior to C&A receiving the initial consideration provided for herein.

Thank you for your interest and participation. I look forward to a prosperous business 

relationship and await your future visit to CannaMED’s Maryland Eastern Shore facility.

Sincerely,

Agreed:

Jeffrey M. Siskind

___________________________________

Case 19-01298-MAM Doc 473-22 Filed 10/22/20 Page 3 of 3